GTHX Annual Cash & Cash Equivalents
$32.22 M
-$62.38 M-65.94%
31 December 2023
Summary:
As of January 22, 2025, GTHX annual cash & cash equivalents is $32.22 million, with the most recent change of -$62.38 million (-65.94%) on December 31, 2023. During the last 3 years, it has fallen by -$175.09 million (-84.46%).GTHX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GTHX Quarterly Cash And Cash Equivalents
$15.07 M
-$4.81 M-24.20%
30 June 2024
Summary:
As of January 22, 2025, GTHX quarterly cash and cash equivalents is $15.07 million, with the most recent change of -$4.81 million (-24.20%) on June 30, 2024. Over the past year, it has dropped by -$40.84 million (-73.04%).GTHX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GTHX Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -65.9% | -73.0% |
| 3 y3 years | -84.5% | -73.0% |
| 5 y5 years | -91.3% | -95.4% |
GTHX Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -91.3% | -96.1% |
G1 Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $15.07 M(-24.2%) |
| Mar 2024 | - | $19.89 M(-38.3%) |
| Dec 2023 | $32.22 M(-65.9%) | $32.22 M(-38.8%) |
| Sept 2023 | - | $52.62 M(-5.9%) |
| June 2023 | - | $55.91 M(-18.1%) |
| Mar 2023 | - | $68.24 M(-27.9%) |
| Dec 2022 | $94.59 M(-57.2%) | $94.59 M(+1.5%) |
| Sept 2022 | - | $93.24 M(-35.2%) |
| June 2022 | - | $143.96 M(-21.3%) |
| Mar 2022 | - | $183.02 M(-17.3%) |
| Dec 2021 | $221.19 M(+6.7%) | $221.19 M(+4.3%) |
| Sept 2021 | - | $212.09 M(-13.1%) |
| June 2021 | - | $244.02 M(-12.5%) |
| Mar 2021 | - | $278.97 M(+34.6%) |
| Dec 2020 | $207.31 M | $207.31 M(-13.0%) |
| Sept 2020 | - | $238.34 M(+1.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2020 | - | $234.27 M(-3.4%) |
| Mar 2020 | - | $242.40 M(-10.0%) |
| Dec 2019 | $269.21 M(-27.1%) | $269.21 M(-10.2%) |
| Sept 2019 | - | $299.93 M(-7.7%) |
| June 2019 | - | $324.91 M(-6.6%) |
| Mar 2019 | - | $347.80 M(-5.8%) |
| Dec 2018 | $369.29 M(+255.7%) | $369.29 M(-5.4%) |
| Sept 2018 | - | $390.52 M(+107.5%) |
| June 2018 | - | $188.23 M(-3.2%) |
| Mar 2018 | - | $194.39 M(+87.2%) |
| Dec 2017 | $103.81 M(+119.5%) | $103.81 M(-12.3%) |
| Sept 2017 | - | $118.38 M(-10.8%) |
| June 2017 | - | $132.68 M(+251.7%) |
| Mar 2017 | - | $37.73 M(-20.2%) |
| Dec 2016 | $47.30 M(+106.2%) | $47.30 M |
| Dec 2015 | $22.94 M | - |
FAQ
- What is G1 Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for G1 Therapeutics?
- What is G1 Therapeutics annual cash & cash equivalents year-on-year change?
- What is G1 Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for G1 Therapeutics?
- What is G1 Therapeutics quarterly cash and cash equivalents year-on-year change?
What is G1 Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of GTHX is $32.22 M
What is the all time high annual cash & cash equivalents for G1 Therapeutics?
G1 Therapeutics all-time high annual cash & cash equivalents is $369.29 M
What is G1 Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, GTHX annual cash & cash equivalents has changed by -$62.38 M (-65.94%)
What is G1 Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of GTHX is $15.07 M
What is the all time high quarterly cash and cash equivalents for G1 Therapeutics?
G1 Therapeutics all-time high quarterly cash and cash equivalents is $390.52 M
What is G1 Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, GTHX quarterly cash and cash equivalents has changed by -$40.84 M (-73.04%)